The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy

Agoston Gyula Szabo; Jonathan Thorsen; Katrine Fladeland Iversen; Mette Bøegh Levring; Birgitte Preiss; Carsten Helleberg; Marie Fredslund Breinholt; Emil Hermansen; Lise Mette Rahbek Gjerdrum; Søren Thorgaard Bønløkke; Katrine Nielsen; Eigil Kjeldsen; Elena Manuela Teodorescu; Marveh Dokhi; Eva Kurt; Casper Nørgaard Strandholdt; Mette Klarskov Andersen; Annette Juul Vangsted

doi:10.1002/ajh.26449

The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy

Agoston Gyula Szabo^*, Jonathan Thorsen, Katrine Fladeland Iversen, Mette Bøegh Levring, Birgitte Preiss, Carsten Helleberg, Marie Fredslund Breinholt, Emil Hermansen, Lise Mette Rahbek Gjerdrum, Søren Thorgaard Bønløkke, Katrine Nielsen, Eigil Kjeldsen, Elena Manuela Teodorescu, Marveh Dokhi, Eva Kurt, Casper Nørgaard Strandholdt, Mette Klarskov Andersen, Annette Juul Vangsted

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › Research › peer-review

1 Citation (Scopus)

Original language	English
Journal	American Journal of Hematology
Volume	97
Issue number	3
Pages (from-to)	E117-E120
Number of pages	4
ISSN	0361-8609
DOIs	https://doi.org/10.1002/ajh.26449
Publication status	Published - 1 Mar 2022

Access to Document

10.1002/ajh.26449

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Szabo, A. G., Thorsen, J., Iversen, K. F., Levring, M. B., Preiss, B., Helleberg, C., Breinholt, M. F., Hermansen, E., Gjerdrum, L. M. R., Bønløkke, S. T., Nielsen, K., Kjeldsen, E., Teodorescu, E. M., Dokhi, M., Kurt, E., Strandholdt, C. N., Andersen, M. K., & Vangsted, A. J. (2022). The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy. American Journal of Hematology, 97(3), E117-E120. https://doi.org/10.1002/ajh.26449

@article{4d0612bb0c79432295bd5d8e923472a9,

title = "The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy",

author = "Szabo, {Agoston Gyula} and Jonathan Thorsen and Iversen, {Katrine Fladeland} and Levring, {Mette B{\o}egh} and Birgitte Preiss and Carsten Helleberg and Breinholt, {Marie Fredslund} and Emil Hermansen and Gjerdrum, {Lise Mette Rahbek} and B{\o}nl{\o}kke, {S{\o}ren Thorgaard} and Katrine Nielsen and Eigil Kjeldsen and Teodorescu, {Elena Manuela} and Marveh Dokhi and Eva Kurt and Strandholdt, {Casper N{\o}rgaard} and Andersen, {Mette Klarskov} and Vangsted, {Annette Juul}",

year = "2022",

month = mar,

day = "1",

doi = "10.1002/ajh.26449",

language = "English",

volume = "97",

pages = "E117--E120",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "Wiley",

number = "3",

}

Szabo, AG, Thorsen, J, Iversen, KF, Levring, MB, Preiss, B, Helleberg, C, Breinholt, MF, Hermansen, E, Gjerdrum, LMR, Bønløkke, ST, Nielsen, K, Kjeldsen, E, Teodorescu, EM, Dokhi, M, Kurt, E, Strandholdt, CN, Andersen, MK & Vangsted, AJ 2022, 'The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy', American Journal of Hematology, vol. 97, no. 3, pp. E117-E120. https://doi.org/10.1002/ajh.26449

The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy. / Szabo, Agoston Gyula; Thorsen, Jonathan; Iversen, Katrine Fladeland et al.
In: American Journal of Hematology, Vol. 97, No. 3, 01.03.2022, p. E117-E120.

Research output: Contribution to journal › Comment/debate › Research › peer-review

TY - JOUR

T1 - The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy

AU - Szabo, Agoston Gyula

AU - Thorsen, Jonathan

AU - Iversen, Katrine Fladeland

AU - Levring, Mette Bøegh

AU - Preiss, Birgitte

AU - Helleberg, Carsten

AU - Breinholt, Marie Fredslund

AU - Hermansen, Emil

AU - Gjerdrum, Lise Mette Rahbek

AU - Bønløkke, Søren Thorgaard

AU - Nielsen, Katrine

AU - Kjeldsen, Eigil

AU - Teodorescu, Elena Manuela

AU - Dokhi, Marveh

AU - Kurt, Eva

AU - Strandholdt, Casper Nørgaard

AU - Andersen, Mette Klarskov

AU - Vangsted, Annette Juul

PY - 2022/3/1

Y1 - 2022/3/1

UR - http://www.scopus.com/inward/record.url?scp=85122077675&partnerID=8YFLogxK

U2 - 10.1002/ajh.26449

DO - 10.1002/ajh.26449

M3 - Comment/debate

C2 - 34967035

SN - 0361-8609

VL - 97

SP - E117-E120

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 3

ER -

The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy

Access to Document

AUB Link

Other files and links

Cite this